Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Boston Scientific Corporation | INDUSTRY |
| Queen Mary University of London | OTHER |
Not provided
Not provided
Not provided
Pilot randomised trial to assess recruitment for a larger trial to compare the efficacy and adverse effects of the subcutaneous and transvenous ICD in patients with hypertrophic cardiomyopathy (HCM) and indication for ICD therapy, with no requirement for pacing
This study aims to test the feasibility of conducting a trial to investigate the use of subcutaneous implantable defibrillator (SICD) in patients with hypertrophic cardiomyopathy (HCM) and to determine whether SICD produces more complications than conventional, transvenous implantable defibrillator (TV ICD).
The primary analysis for the main trial is designed to test whether the S-ICD is non-inferior to the TV-ICD with respect to the primary endpoint of inappropriate shock treatment and complications. For the incidence of the primary endpoint statistical significance and 99% confidence intervals are calculated using Cox' proportional hazards model. Non-inferiority is considered to be established if the upper boundary of the one-sided 99% confidence interval did not exceed 1.92 (absolute difference < 12%).
Participant duration is expected to be 14 months. (12 months follow up post device implant) Recruitment duration expected to be 6-10 months.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Transvenous Implantable Defibrillator | Active Comparator | Routine TV ICD implant |
|
| Subcutaneous Implantable Defibrillator | Active Comparator | SICD ICD implant as per study protocol |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Implantable Cardioverter Defibrillator implant | Device | ICD implant to protect patients from life threatening ventricular tachycardia or ventricular fibrillation |
|
| Measure | Description | Time Frame |
|---|---|---|
| Rate of recruitment | Assessment of rate of recruitment per month | through study completion, expected at 10 months to 1 year |
| Composite of inappropriate shock and ICD related complications | Rate of inappropriate shocks and ICD related complications across the patients over a 12 month period. | 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| All- cause mortality | % of patients who die | 12 months |
| MACE events | Major Adverse Cardiac Event (MACE), defined as cardiac death, myocardial infarction, percutaneous coronary intervention, coronary artery bypass grafting and/or any valve surgery. |
| Measure | Description | Time Frame |
|---|---|---|
| Drop out rate | % of patients that do not complete the sudy | 12 months |
| Data Quality | % of data completed | 12 months |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| St Bartholomew's Hospital | London | EC1A 7BE | United Kingdom |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Pilot randomised control trial, randomised 1:1 for Transvenous: Subcutaneous
Not provided
Not provided
Not provided
Not provided
| 12 months |
| Appropriate shocks and patients with appropriate shocks | Rate over 12 months determined by IBHRE accredited Cardiac Scientist | 12 months |
| Inappropriate shocks and patients with inappropriate shocks | Rate over 12 months determined by IBHRE accredited Cardiac Scientist | 12 months |
| Complications | individually, defined as infections, bleedings, thrombotic events, pneumothorax, perforation/tamponade, lead reposition and lead- or device failures | 12 months |
| Cardiac decompensation | Measured by admissions for Heart failure or unplanned outpatient appointments. | 12 months |
| Crossovers to the other arm | Amount of patients moving from SICD to TV group and visa versa over 12 month period. | 12 months |
| Appropriate shock treatment in ATP or monitor zone | Rate over 12 months determined by IBHRE accredited Cardiac Scientist | 12 months |
| Quality of life assessed by SF-36 survey | Scores for the different domains are converted and pooled using a scoring key, for a total score indicating a range of low to high QOL. | 12 months |
| Quality of life assessed by EQ5D survey | Scores for the different domains are converted and pooled using a scoring key, for a total score indicating a range of low to high QOL. | 12 months |
| Cardiac (pre-) syncope events | rate of patients with these events over a 12 month period | 12 months |
| Time to successful therapy | Time in months or days from implant to date of succesful therapy | 12 months |
| First shock conversion efficacy | % of first shocks that cardiovert ventricular arrhythmia | 12 months |
| Implant procedure time | Duration of implant from needle to skin to skin closure. | Procedure duration- average of 2 hours expected |
| Hospitalization rate | Rate of patient hospitalisation for cardiac and non-cardiac causes over a 12 month period. | 12 months |
| Fluoroscopy time | Amount of fluoroscopy required to complete implant procedure, expected fluoroscopy time of approximately 1 minute per patient. | Procedure duration- average of 2 hours expected |
| Eligibility of SICD | % Of patients referred for recruitment was SICD screening making patients illegible. Either Yes or no. | 12 months |
| ID | Term |
|---|---|
| D002312 | Cardiomyopathy, Hypertrophic |
| ID | Term |
|---|---|
| D009202 | Cardiomyopathies |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D001020 | Aortic Stenosis, Subvalvular |
| D001024 | Aortic Valve Stenosis |
| D000082862 | Aortic Valve Disease |
| D006349 | Heart Valve Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D017147 | Defibrillators, Implantable |
| ID | Term |
|---|---|
| D047548 | Defibrillators |
| D004566 | Electrodes |
| D055615 | Electrical Equipment and Supplies |
| D004864 | Equipment and Supplies |
| D004567 | Electrodes, Implanted |
| D019736 | Prostheses and Implants |
Not provided
Not provided